Better glycemic control reduces complications associated with type 2 diabetes (T2D) by at least 50 percent; unfortunately, a large percentage of patients with this disease continue to exhibit poor glycemic...
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
In this podcast, Peter Jones, MD, gives a preview of his presentation on the prevention of cardiovascular disease and the treatment of dyslipidemia, which will be presented at the Practical Updates in...
